FDA Resource on Investigational Drugs
In late 2009, the U.S. Food and Drug Administration (FDA) approved new rules designed to allow seriously ill patients greater access to investigational, or trial, drugs. Investigational drugs may be made available to a participant in a clinical trial, or to others under an expanded access (or “compassionate use”) program.
Want to learn more? Visit the FDA Web site at www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/AccesstoInvestigationalDrugs/default.htm.